Effect of lycopene and metformin combination on phagocytosis, glycemic control, and oxidative stress in rats with type 2 diabetes

Authors

  • Medina Sianturi Department of Nursing, STIKES Elisabeth Semarang, Semarang, Indonesia; Doctoral of Medical Science and Health Study Program, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia https://orcid.org/0000-0002-3914-375X
  • Neni Susilaningsih Department of Histology, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia https://orcid.org/0000-0003-1960-507X
  • Heri Nugroho Department of Internal Medicine, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia
  • Nyoman Suci Department of Clinical Pathology, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia https://orcid.org/0000-0002-4083-1293
  • Tri Nur Kristina Department of Medical Education, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia https://orcid.org/0000-0002-4336-1450
  • Maria Suryani Department of Nursing, STIKES Elisabeth Semarang, Semarang, Indonesia https://orcid.org/0000-0002-8867-8339

DOI:

https://doi.org/10.13181/mji.oa.236774

Keywords:

glycemic control, lycopene, metformin, oxidative stress, phagocytosis

Abstract

BACKGROUND Hyperglycemia and oxidative stress cause phagocytosis dysfunction in patients with diabetes. A combination of lycopene and metformin can reduce oxidative stress and blood glucose. This study aimed to determine the effect of combined lycopene and metformin on phagocytosis function, glycated hemoglobin A1c (HbA1c), nitric oxide (NO), reactive oxygen species (ROS), and advanced glycation end products (AGEs).

METHODS A randomized controlled study was conducted in rats at the Center for Food and Nutrition Studies, Universitas Gadjah Mada, Yogyakarta, Indonesia, from August to September 2022. 30 rats were divided into control (n = 5) and type 2 diabetes mellitus (T2DM) (n = 25) groups. Rats in the T2DM group were induced by a high-fat diet combined with streptozotocin-nicotinamide. The 25 rats were then divided into five subgroups: 1 ml coconut oil (DM), 250 mg/kg metformin in 1 ml coconut oil (DMet), 250 mg/kg metformin + 10 mg/kg lycopene in 1 ml coconut oil (DML-10), 250 mg/kg metformin + 20 mg/kg lycopene in 1 ml coconut oil (DML-20), and 250 mg/kg metformin + 40 mg/kg lycopene in 1 ml coconut oil (DML-40). Treatments were administered daily for 4 weeks. The macrophage phagocytosis index (PI), HbA1c levels, ROS, NO, and AGEs serum were evaluated.

RESULTS There was a significant difference in the PI, HbA1c, NO, ROS, and AGEs between the groups (p<0.001). The DML-20 and DML-40 groups had significantly increased PI and decreased NO, ROS, and AGEs levels than metformin alone (p<0.05).

CONCLUSIONS Lycopene combined with metformin could improve phagocytosis function, glycemic control, and oxidative stress.

Downloads

Download data is not yet available.

References

Insuela D, Coutinho D, Martins M, Ferrero M, Carvalho V. Neutrophil function impairment is a host susceptibility factor to bacterial infection in diabetes. Cells of the Immune System. IntechOpen; 2020. https://doi.org/10.5772/intechopen.86600

Fachinello MR, Fernandes NLM, de Souto ER, dos Santos TC, da Costa AER, Pozza PC. Lycopene affects the immune responses of finishing pigs. Ital J Anim Sci. 2018;17(3):666-74. https://doi.org/10.1080/1828051X.2017.1401438

Pavlou S, Lindsay J, Ingram R, Xu H, Chen M. Sustained high glucose exposure sensitizes macrophage responses to cytokine stimuli but reduces their phagocytic activity. BMC Immunol. 2018;19(1):24. https://doi.org/10.1186/s12865-018-0261-0

Wang R, Sheng M, Shi F, Zhao Y, Zhao L, Wu J, et al. Dysfunctional phagocytosis capacity, granulocyte recruitment and inflammatory factor secretion of Kupffer cells in diabetes mellitus reversed by lidocaine. Diabetes Metab Syndr Obes. 2018;11:827-34. https://doi.org/10.2147/DMSO.S186695

Lecube A, Pachón G, Petriz J, Hernández C, Simó R. Phagocytic activity is impaired in type 2 diabetes mellitus and increases after metabolic improvement. PLoS One. 2011;6(8):e23366. https://doi.org/10.1371/journal.pone.0023366

Chang CH, Wang JL, Wu LC, Chuang LM, Lin HH. Diabetes, glycemic control, and risk of infection morbidity and mortality: a cohort study. Open Forum Infect Dis. 2019;6(10):ofz358. https://doi.org/10.1093/ofid/ofz358

Huang J, Xiao Y, Zheng P, Zhou W, Wang Y, Huang G, et al. Distinct neutrophil counts and functions in newly diagnosed type 1 diabetes, latent autoimmune diabetes in adults, and type 2 diabetes. Diabetes Metab Res Rev. 2019;35(1):e3064. https://doi.org/10.1002/dmrr.3064

Berezin A. Metabolic memory phenomenon in diabetes mellitus: achieving and perspectives. Diabetes Metab Syndr Clin Res Rev. 2016;10(2):S176-83. https://doi.org/10.1016/j.dsx.2016.03.016

Adela R, Nethi SK, Bagul PK, Barui AK, Mattapally S, Kuncha M, et al. Hyperglycaemia enhances nitric oxide production in diabetes: a study from South Indian patients. PLoS One. 2015;10(4):e0125270. https://doi.org/10.1371/journal.pone.0125270

Ridzuan N, John CM, Sandrasaigaran P, Maqbool M, Liew LC, Lim J, et al. Preliminary study on overproduction of reactive oxygen species by neutrophils in diabetes mellitus. World J Diabetes. 2016;7(13):271-8. https://doi.org/10.4239/wjd.v7.i13.271

Indyk D, Bronowicka-Szyde?ko A, Gamian A, Kuzan A. Advanced glycation end products and their receptors in serum of patients with type 2 diabetes. Sci Rep. 2021;11(1):1-14. https://doi.org/10.1038/s41598-021-92630-0

American Diabetes Association. Standards of medical care in diabetes-2020 abridged for primary care providers. Clin Diabetes. 2020;38(1):10-38. https://doi.org/10.2337/cd20-as01

Cheng G, Lanza-Jacoby S. Metformin decreases growth of pancreatic cancer cells by decreasing reactive oxygen species: role of NOX4. Biochem Biophys Res Commun. 2015;465(1):41-6. https://doi.org/10.1016/j.bbrc.2020.03.061

Liu Y, Huang C, Ceng C, Zhan H, Zheng D, Han W. Metformin enhances nitric oxide production and diminishes Rho kinase activity in rats with hyperlipidemia. Lipids Health Dis. 2014;13(1):115. https://doi.org/10.1186/s12944-018-0755-z

Figueiredo ID, Lima TFO, Inácio MD, Costa MC, Assis RP, Brunetti IL, et al. Lycopene improves the metformin effects on glycemic control and decreases biomarkers of glycoxidative stress in diabetic rats. Diabetes Metab Syndr Obes. 2020;13:3117-35. https://doi.org/10.2147/DMSO.S265944

Saeed NM, Mansour AM, Allam S. Lycopene induces insulin signaling and alleviates fibrosis in experimental model of non-alcoholic fatty liver disease in rats. PharmaNutrition. 2020;14:100225. https://doi.org/10.1016/j.phanu.2020.100225

Guerra BA, Otton R. Impact of the carotenoid astaxanthin on phagocytic capacity and ROS/RNS production of human neutrophils treated with free fatty acids and high glucose. Int Immunopharmacol. 2011;11(12):2220-6. https://doi.org/10.1016/j.intimp.2011.10.004

Tabrez S, Al-Shali KZ, Ahmad S. Lycopene powers the inhibition of glycation-induced diabetic nephropathy: a novel approach to halt the AGE-RAGE axis menace. Biofactors. 2015;41(5):372-81. https://doi.org/10.1002/biof.1238

Leh HE, Mohd Sopian M, Abu Bakar MH, Lee LK. The role of lycopene for the amelioration of glycaemic status and peripheral antioxidant capacity among the type II diabetes mellitus patients: a case-control study. Ann Med. 2021;53(1):1059-65. https://doi.org/10.1080/07853890.2021.1943515

Haribabu T, Divakar K, Goli D. Evaluation of anti-diabetic activity of lycopene and its synergistic effect with metformin hydrochloride and glipizide in alloxan induced diabetes in rats. Sch Acad J Pharm. 2013;2(2):119-24.

Ghasemi A, Khalifi S, Jedi S. Streptozotocin-nicotinamide-induced rat model of type 2 diabetes (review). Acta Physiol Hung. 2014;101(4):408-20. https://doi.org/10.1556/APhysiol.101.2014.4.2

Eze ED, Afodun AM, Kasolo J, Kasozi KI. Lycopene improves on basic hematological and immunological parameters in diabetes mellitus. BMC Res Notes. 2019;12(1):805. https://doi.org/10.1186/s13104-019-4841-8

Tang Q, Su YW, Xian CJ. Determining oxidative damage by lipid peroxidation assay in rat serum. Bio Protoc. 2019;9(12):e3263. https://doi.org/10.21769/BioProtoc.3263

Wahdaningsih S, Wahyuono S, Riyanto S, Murwanti R. In vitro test of macrophage phagocytic activity of extracts and fractions of red dragon fruit peel [Hylocereus polyrhizus (F.A.C.Weber) Britton and Rose]. Dhaka Univ J Pharm Sci. 2018;17(2):161-5. https://doi.org/10.3329/dujps.v17i2.39171

Durairajanayagam D, Agarwal A, Ong C, Prashast P. Lycopene and male infertility. Asian J Androl. 2014;16(3):420-5. https://doi.org/10.4103/1008-682X.126384

Imran M, Ghorat F, Ul-Haq I, Ur-Rehman H, Aslam F, Heydari M, et al. Lycopene as a natural antioxidant used to prevent human health disorders. Antioxidants (Basel). 2020;9(8):706. https://doi.org/10.3390/antiox9080706

Published

2023-07-24

How to Cite

1.
Sianturi M, Susilaningsih N, Nugroho H, Suci N, Kristina TN, Suryani M. Effect of lycopene and metformin combination on phagocytosis, glycemic control, and oxidative stress in rats with type 2 diabetes. Med J Indones [Internet]. 2023Jul.24 [cited 2024Nov.19];32(1):1-6. Available from: https://mji.ui.ac.id/journal/index.php/mji/article/view/6774

Issue

Section

Basic Medical Research
Abstract viewed = 353 times